why choose us

First received: December 15, 2024

Clinical Trial: A Study of Dengue Tetravalent Vaccine (TDV) in Healthy Participants in Japan

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Dengue Fever

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-Blind, Placebo-Controlled (Participants Aged 18 to 60 Years) and Open-Label (Participants Aged 4 to 17 Years), Phase 2/3 Trial to Evaluate the Immunogenicity and Safety of 2

Brief Summary: Dengue fever is caused by an infection with the dengue virus.Vaccination with TDV can help prevent dengue fever.The main purpose of this study is to learn about TDV's ability to create an immune response in adults, adolescents, and children administered.In this study, participants will receive 2 vaccinations with TDV (the second 3 months after the first).During the study, participants will visit their study clinic 5 times.Participants will be in this study for approximately 270 days (9 months).

Read more